Skip to main content
. Author manuscript; available in PMC: 2019 May 10.
Published in final edited form as: ACS Infect Dis. 2018 Dec 19;5(5):759–768. doi: 10.1021/acsinfecdis.8b00269

Table 2.

The effect of BA-53038B on HBV capsid (HepG2 cells transiently transfected)

Compound EC50 (μM)
HBV1.3 HBV1.3/core-F97L HBV1.3/core-V124A HBV1.3/core-V124F HBV1.3/core-V124W
DVR23 0.37 ± 0.002 0.45 ± 0.06 1.61 ± 0.05 1.57 ± 0.15 >10
BA-53038B 0.67 ± 0.17 2.18 ± 0.81 0.40 ± 0.13 0.32 ± 0.06 >10

EC50 was determined by real-time PCR assay.